Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)"
Notice Number:
NOT-DA-22-067

Key Dates

Release Date:

August 23, 2022

Related Announcements

RFA-DA-23-032 - NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs applicants of a changes to the Key Dates for Funding Opportunity Announcement (FOA) RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)".

 
The following Section of RFA-DA-23-032 has been modified to reflect the changed dates:

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

November 14, 2022

November 14, 2022

Not Applicable

March 2022

May 2022

July 2022

November 14, 2023

November 14, 2023

Not Applicable

March 2023

May 2023

July 2023

November 14, 2024

November 14, 2024

Not Applicable

March 2024

May 2024

July 2024


Expiration Date:

November 15, 2024


Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

November 14, 2022

November 14, 2022

November 14, 2022

March 2023

May 2023

July 2023

November 14, 2023

November 14, 2023

November 14, 2023

March 2024

May 2024

July 2024

November 14, 2024

November 14, 2024

November 14, 2024

March 2025

May 2025

July 2025


Expiration Date:

November 15, 2024


All other aspects of this FOA remain the same.  

Inquiries

Please direct all inquiries to:

Kathy Etz, PhD
Epidemiology Research Branch
National Institute on Drug Abuse (NIDA)
Telephone: 301 402 1749
Email: ketz@nih.gov


Alexa Romberg, PhD
Prevention Research Branch
National Institute on Drug Abuse NIDA)
Telephone: 301-435-0264
Email: alexa.romberg@nih.gov